Chad Torgerson

Principal Scientist Arbor Biotechnologies

Seminars

Wednesday 30th September 2026
Delivering Prime Editing Within AAV to Unlock Precise In Vivo Gene Editing
11:45 am
  • Showcasing how prime and RT editing technologies can be packaged within AAV to give you insight into a uniquely precise approach to in vivo gene editing
  • Unpacking the engineering challenges of fitting prime editing systems within AAV size constraints to help you understand the innovations enabling this delivery approach
  • Highlighting how AAV-delivered prime editing compares to conventional CRISPR approaches to equip you with a broader perspective on next-generation in vivo editing options
Chad Torgerson, Principal Scientist Arbor Biotechnologies - Expert Speaker at the 7th Genome Editing Therapeutics Summit 2026